Caplin Point Laboratories reports 21% rise in Q1 consolidated net profit

07 Aug 2023 Evaluate

Caplin Point Laboratories has reported results for first quarter ended June 30, 2023 (Q1FY24). 

The company has reported 20.60% rise in its net profit at Rs 76.27 crore for the quarter under review as compared to Rs 63.24 crore for the same quarter in the previous year. Total income of the company increased by 32.75% at Rs 200.93 crore for Q1FY24 as compared Rs 151.36 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 20.76% rise in net profit at Rs 104.23 crore for the first quarter ended June 30, 2023 as compared to Rs 86.31 crore for the same quarter in the previous year. Total income of the company increased by 13.07% at Rs 407.36 crore for Q1FY24 as compared Rs 360.27 crore for the corresponding quarter previous year.

Caplin Point Lab Share Price

2580.05 26.85 (1.05%)
08-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.30
Dr. Reddys Lab 1370.60
Cipla 1495.05
Lupin 2252.40
Zydus Lifesciences 981.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.